Median Gamma-glutamyl transpeptidase (GGT) was significantly higher in the IBD-NAFLD group than in the IBD-only group (32 UI/L and 17 UI/L, respectively; p = 0.002). Here, GGTLC1 is linked to metabolic dysfunction-associated steatotic liver disease.